Search research articles
Contact Us
Filters
Showing results (171-180 of 231) with videos related to
Page
of 24
Sort By:
Current Pharmaceutical Design
|
November 28, 2012
From bortezomib to other inhibitors of the proteasome and beyond
Daniela Buac, Min Shen, Sara Schmitt, et al.
Pharmaceutical Research
|
August 29, 2009
Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice
Subhash Padhye, Sanjeev Banerjee, Deepak Chavan, et al.
Biological Trace Element Research
|
March 17, 2012
Association of metals and proteasome activity in erythrocytes of prostate cancer patients and controls
Christine Neslund-Dudas, Bharati Mitra, Ashoka Kandegedara, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
March 17, 2005
Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells
Deborah Kuhn, Wai Har Lam, Aslamuzzaman Kazi, et al.
Bioorganic & Medicinal Chemistry
|
October 7, 2004
A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]
Wai Har Lam, Aslamuzzaman Kazi, Deborah J Kuhn, et al.
International Journal of Molecular Medicine
|
September 7, 2010
Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors
Sheng Biao Wan, Huanjie Yang, Zhongyuan Zhou, et al.
Cancer Letters
|
May 13, 2008
Anti-tumor activity of N-thiolated beta-lactam antibiotics
Di Chen, Samuel C Falsetti, Michael Frezza, et al.
Cancer Research
|
December 21, 2006
Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells
Ronald P Pelley, Kannagi Chinnakannu, Shalini Murthy, et al.
Expert Opinion on Drug Discovery
|
April 25, 2018
Perspectives on the recent developments with green tea polyphenols in drug discovery
Feng Li, Yongli Wang, Dapeng Li, et al.
Plos One
|
November 25, 2014
Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis
Li Lu, Wenli Shi, Rahul R Deshmukh, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 231) with videos related to
Sort By:
Page
of 24
Current Pharmaceutical Design
|
November 28, 2012
From bortezomib to other inhibitors of the proteasome and beyond
Daniela Buac, Min Shen, Sara Schmitt, et al.
Pharmaceutical Research
|
August 29, 2009
Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice
Subhash Padhye, Sanjeev Banerjee, Deepak Chavan, et al.
Biological Trace Element Research
|
March 17, 2012
Association of metals and proteasome activity in erythrocytes of prostate cancer patients and controls
Christine Neslund-Dudas, Bharati Mitra, Ashoka Kandegedara, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
March 17, 2005
Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells
Deborah Kuhn, Wai Har Lam, Aslamuzzaman Kazi, et al.
Bioorganic & Medicinal Chemistry
|
October 7, 2004
A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]
Wai Har Lam, Aslamuzzaman Kazi, Deborah J Kuhn, et al.
International Journal of Molecular Medicine
|
September 7, 2010
Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors
Sheng Biao Wan, Huanjie Yang, Zhongyuan Zhou, et al.
Cancer Letters
|
May 13, 2008
Anti-tumor activity of N-thiolated beta-lactam antibiotics
Di Chen, Samuel C Falsetti, Michael Frezza, et al.
Cancer Research
|
December 21, 2006
Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells
Ronald P Pelley, Kannagi Chinnakannu, Shalini Murthy, et al.
Expert Opinion on Drug Discovery
|
April 25, 2018
Perspectives on the recent developments with green tea polyphenols in drug discovery
Feng Li, Yongli Wang, Dapeng Li, et al.
Plos One
|
November 25, 2014
Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis
Li Lu, Wenli Shi, Rahul R Deshmukh, et al.
Page
of 24